Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SLE and pregnancy.

E Baguley1, N MacLachlan, G R Hughes

  • 1Lupus Arthritis Research Unit, Rayne Institute, St. Thomas' Hospital, London, U.K.

Clinical and Experimental Rheumatology
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS).

Annals of the rheumatic diseases·2007
Same author

Images in medicine. Large airway involvement in relapsing polychondritis.

Hospital medicine (London, England : 1998)·2001
Same author

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients.

Lupus·1998
Same author

Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome.

The Journal of rheumatology·1998
Same author

Most anticardiolipin antibodies in mixed connective tissue disease are beta2-glycoprotein independent.

The Journal of rheumatology·1998
Same author

Immunological findings in Kawasaki disease: an evaluation in a cohort of Italian children.

Clinical and experimental rheumatology·1998

Pregnancy in patients with Systemic Lupus Erythematosus (SLE) in remission poses minimal risk. Treatment for SLE flares during pregnancy is recommended, as maternal disease poses a greater risk to the fetus than therapy.

Area of Science:

  • Rheumatology
  • Obstetrics
  • Immunology

Background:

  • Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect pregnant patients.
  • Managing SLE during pregnancy requires careful consideration of maternal and fetal risks.

Purpose of the Study:

  • To evaluate the safety and risks of pregnancy in women with SLE.
  • To provide guidance on managing SLE disease activity and medications during pregnancy.

Main Methods:

  • Review of existing literature and clinical guidelines regarding SLE and pregnancy.
  • Analysis of risks associated with maternal SLE disease activity and immunoregulatory therapies.

Main Results:

  • Pregnancy in SLE patients in remission generally does not pose significant risks to mother or fetus.

Related Experiment Videos

  • Withholding immunoregulatory drugs or therapies for flares is not advised due to higher risks from uncontrolled maternal disease.
  • Therapeutic abortion is rarely indicated, even in active SLE cases.

    • Conclusions:

    • SLE patients in remission can safely conceive and carry pregnancies to term.
    • Continued or initiated therapy for SLE flares during pregnancy is crucial for favorable outcomes.
    • Antiphospholipid antibodies (aPL) require careful management, with optimal treatment strategies still under investigation for specific patient groups.